Clinical Trial

Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease

Name: Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease — clinical trial record (NCT07739368)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine whether Ferric Maltol, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease (IBD).

Trial Details

NCT Number	NCT07739368
Lead Sponsor	Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Conditions	Iron Deficiency Anaemia
Enrollment	122 participants
Start Date	2021-09-01
Primary Completion	2025-02-20 (estimated)
Study Completion	2025-03-20 (estimated)
Updated on ClinicalTrials.gov	2026-07-31